Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 20 di 282
Titolo Data di pubblicazione Autore(i) File
OSMOREGULATION OF VASOPRESSIN DURING ACUTE LOWERING OF ARTERIAL-PRESSURE BY CLONIDINE IN MODERATE HYPERTENSION 1-gen-1989 Delbo, A; Marabini, M; Aghemo, A; Zanchetti, A
REGULATION OF VASOPRESSIN SECRETION AFTER ADMINISTRATION OF SODIUM-NITROPRUSSIDE IN HYPERTENSIVES 1-gen-1991 Delbo, A; Marabini, M; Aghemo, A; Maffi, M; Suraci, S; Zanchetti, A
COINCIDENCE OF CALCITONIN-GENE-RELATED PEPTIDE IMMUNOREACTIVITY AND TERMINAL FIELDS OF EFFERENTS FROM THE CARDIOVASCULAR PORTION OF THE FASTIGIAL NUCLEUS - PRELIMINARY-REPORT 1-gen-1993 Aghemo, A; Morara, S; Delbo, A; Rosina, A
US features of liver surface nodularity as a predictor of severe fibrosis in chronic hepatitis C 1-gen-2005 Vigano, M; Visentin, S; Aghemo, A; Rumi, Mg; Ronchi, G
The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies 1-gen-2005 Monti, V; Aghemo, A; Rumi, Mg; Donato, Mf; Del Ninno, E; Colombo, M
The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia 1-gen-2006 Rumi, Mg; D'Ambrosio, R; Aghemo, A
Impaired response to interferon-alpha 2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection 1-gen-2006 Aghemo, A; Rumi, Mg; Soffredini, R; D'Ambrosio, R; Ronchi, G; Del Ninno, E; Gallus, S; Colombo, M
Lack of rapid virological response. predicts interferon-alpha 2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre study 1-gen-2007 Rumi, Mg; Aghemo, A; D'Ambrosio, R; Ronchi, G; Del Ninno, E; Gallus, S; Colombo, M
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis 1-gen-2007 Vigano, M; Aghemo, A; Iavarone, M
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection 1-gen-2007 Taliani, G; Rucci, P; Biliotti, E; Cirrincione, L; Aghemo, A; Alberti, A; Almasio, Pl; Bartolozzi, D; Caporaso, N; Coppola, R; Chiaramonte, M; Floreani, A; Gaeta, Gb; Persico, M; Secchi, G; Versace, I; Zacharia, S; Mele, A
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients 1-gen-2008 Aghemo, A.; Rumi, M.; Prati, G. M.; Monico, S.; Donato, M. F.; Colombo, M.
Low risk of hepatitis B reactivation in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin 1-gen-2008 Iavarone, M.; Aghemo, A.; Viganò, M.; Rumi, M. G.; Agnelli, F.; Lampertico, P.; Donato, M. F.; Colombo, M.
Increased risk of hepatocellular carcinoma in HCV (+) non responder cirrhotics with high liver cell proliferation 1-gen-2008 Donato, M. F.; Arosio, E.; Aghemo, A.; Rumi, M. G.; Ronchi, G.; Colombo, M.
Low risk of hepatitis B reactivatioin in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin 1-gen-2008 Aghemo, A.; Viganò, M.; Iavarone, M.; Rumi, M. G.; Agnelli, F.; Lampertico, P.; Donato, M. F.; Colombo, M.
Genotype dependent pattern of Peginterferon alfa-2B/Ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis : a single centre study of 471 naïve patients 1-gen-2008 Aghemo, A.; Rumi, M.; Monico, S.; Prati, G. M.; Ronchi, G.; Colombo, M.
Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatiti sC virus infected patients with cirrhosis : a single center study of 471 naive patients 1-gen-2008 Aghemo, A.; Rumi, M.; Monico, S.; Prati, G. M.; Ronchi, G.; Colombo, M.
Optimizing treatment with pegylated interferon-ribavirin of genotype 3 chronic hepatitis C : more questions than answers 1-gen-2008 Aghemo, A.; D’Ambrosio, R.; Rumi, M. G.; Colombo, M.
Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis 1-gen-2008 Stroffolini, T.; Almasio, P. L.; Persico, M.; Bollani, S.; Benvegnù, L.; Di Costanzo, G.; Pastore, G.; Aghemo, A.; Stornaiuolo, G.; Mangia, A.; Andreone, P.; Stanzione, M.; Mazzella, G.; Saracco, G.; Del Poggio, P.; Bruno, S.; Association of the Study of the Liver Disease, Italian
Recovery after L-DOPA treatment in peg-interferon and ribavirin induced parkinsonism 1-gen-2008 Bersano, A.; Aghemo, A.; Rumi, M.; Ballabio, E.; Candelise, L.; Colombo, M.
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics? 1-gen-2008 Aghemo, A; Rumi, Mg; Colombo, M
Mostrati risultati da 1 a 20 di 282
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile